Biomaterial Database

[Some new drugs with cardio-vascular action]. 1950

J F MERLEN

UI	MeSH Term	Description	Entries
D007666	Khellin	A vasodilator that also has bronchodilatory action. It has been employed in the treatment of angina pectoris, in the treatment of asthma, and in conjunction with ultraviolet light A, has been tried in the treatment of vitiligo. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1024)	Visammin
D002018	Bufanolides	Cyclopentanophenanthrenes with a 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. They are found in BUFONIDAE and often possess cardiotonic properties.	Bufadienolides
D002318	Cardiovascular Diseases	Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.	Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002967	Claviceps	A genus of ascomycetous fungi, family Clavicipitaceae, order Hypocreales, parasitic on various grasses (POACEAE). The sclerotia contain several toxic alkaloids. Claviceps purpurea on rye causes ERGOTISM.	Ergot Fungus,Claviceps purpurea,Sphacelia segetum,Fungus, Ergot
D003529	Cymarine	A cardiotonic cardiac glycoside found in STROPHANTHUS. The aglycone is STROPHANTHIN.	h-Strophanthin,k-Strophanthin-alpha,Cymarin,Strophantisel,Tsimarin,Zimarin,h Strophanthin,k Strophanthin alpha
D004876	Ergot Alkaloids	Alkaloids originally isolated from the ergot fungus Claviceps purpurea (Hypocreaceae). They include compounds that are structurally related to ergoline (ERGOLINES) and ergotamine (ERGOTAMINES). Many of the ergot alkaloids act as alpha-adrenergic antagonists.	Clavine Alkaloids,Alkaloids, Clavine,Alkaloids, Ergot
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J F MERLEN

[Some new drugs with the action on hyperlipidemia].

January 1968, Medicinski pregled,

J F MERLEN

Cardio vascular responses and antifibrillatory action of some newly synthesized lignocaine analogues.

June 1966, Arzneimittel-Forschung,

J F MERLEN

SOME CARDIO-VASCULAR ACTIONS OF THIORIDAZINE HYDROCHLORIDE.

August 1963, Archives internationales de pharmacodynamie et de therapie,

J F MERLEN

Some recent papers on Cardio-Vascular Conditions.

January 1911, Canadian Medical Association journal,

J F MERLEN

[Analysis of the action of cardio-active drugs].

November 1986, Archiv der Pharmazie,

J F MERLEN

[A new paradigm of Cardio-Thoracic and Vascular Surgery: some historical aspects and evolution].

January 2013, Revista portuguesa de cirurgia cardio-toracica e vascular : orgao oficial da Sociedade Portuguesa de Cirurgia Cardio-Toracica e Vascular,

J F MERLEN

[New drugs with antineoplastic action].

November 1962, La Clinica terapeutica,

J F MERLEN

[Pharmacogenomics and pharmacoproteomics: a strategy for cardio-vascular drugs].

May 2007, Annales pharmaceutiques francaises,

J F MERLEN

Cardio-vascular conditioning and rehabilitation: a mandate for action.

November 1972, The Journal of the Arkansas Medical Society,

J F MERLEN

[Cardio-vascular effects of sildenafil: new data].

December 2002, Annales de cardiologie et d'angeiologie,